The Comprehensive Aortic Program at CU Anschutz is grounded in a multidisciplinary, translational research model that bridges basic science, clinical investigation, and innovative technology. We integrate advanced imaging, computational modeling, molecular biology, and surgical innovation to better understand aortic diseases across the full spectrum—from genetic predisposition and biomechanical stress to acute aortic syndromes and complex repairs.
Our research is patient-centered, data-driven, and deeply collaborative. We actively engage with divisions of cardiothoracic surgery, vascular surgery, radiology, cardiology, and genetics, as well as national and international research consortia. By combining prospective clinical trials, large-scale registries, and bench-to-bedside innovation, we aim to advance both understanding and treatment of aortic disease.
Founding member of the Western Aortic Collaborative (WAC) a hybrid, multi-institutional academic model uniting aortic surgeons in the Western U.S. with these core goals:
Below is a list of clinical trials our program has participated in.
Please note: This list is not updated regularly, and the current status or availability of each trial may not be reflected. For the most accurate and up-to-date information—or to find out if you are eligible for a clinical trial related to your aortic condition—please schedule an appointment with our team.
Schedule an Appointment
| Trial | Principal Investigator | Focus | Status |
|---|---|---|---|
| ARISE II | Reece, Jacobs | Multi-center FDA approved study to investigate GORE minimally invasive endovascular stent for ascending aorta | Open |
| ARISE III | Reece | Evaluation of GORE ascending stent graft in the treatment new type A aortic dissection | In startup |
| ARTIZEN | Reece | To assess the performance, safety, and effectiveness of the Arcevo™LSA, which is intended for the surgical treatment of patients with acute, subacute, or chronic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta | In startup |
| EXTEND | Reece | Post-market study to evaluate the Thoraflex Hybrid device alone and in combination with the RelayPro NBS stent-graft | Open |
| IMPROVE-AD | Reece, Jacobs | Assess clinical outcomes in patients with subacute uncomplicated type B aortic dissection undergoing upfront thoracic endovascular aortic repair (TEVAR) + medical therapy vs. a strategy of medical therapy with standard of care surveillance for deterioration | Open |
| MRI Brain | Reece | Pre-operative and post-operative imaging to observe the presence of new silent brain emboli after coronary artery bypass graft (CABG), aortic arch and hemiarch surgery | Open |
| MRI Hemiarch | Schafer | Analysis of aortic flow hemodynamic state pre- and post- hemiarch repair in patients with the ascending aortic aneurysm (pilot study) | Open |
| PANTHER | Reece | Collect real world, post-approval safety and performance data on patients treated with Terumo Aortic grafts and patches in standard clinical practice | Open |
| RapidLink | Reece | To evaluate the safety and effectiveness of the RapidLink device in the repair or replacement of the supra-aortic vessels during open surgical repair of aortic disease affecting the thoracic aorta | In startup |